Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Bioinformatician at CNIO, Madrid, Spain

    Bioinformatician for the Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain

    Description:
    The Human Genetics Group is looking for a bioinformatician with experience in data analysis generated by massive sequencing in order to investigate and analyze families with cancer.

    We require:
    • A PhD or BD in any area of Molecular Biology.
    • More than three years of experience in Bioinformatics with publications in this area and molecular biology.
    • Development of bioinformatics software in general, good knowledge of data bases and methodology of massive sequencing
    • Good knowledge of the literature about cancer genome and genetic diseases.
    • Capacity for projects management and cooperation in international projects


    We offer:

    A job in an excellence Centre which has multiple national and international collaborations. Salary is depending of the experience and degree. The incorporation would be immediate.

    Candidates will contact with [email protected] including his/her CV and at least two reference names

Latest Articles

Collapse

  • seqadmin
    Essential Discoveries and Tools in Epitranscriptomics
    by seqadmin




    The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...
    04-22-2024, 07:01 AM
  • seqadmin
    Current Approaches to Protein Sequencing
    by seqadmin


    Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
    04-04-2024, 04:25 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 11:49 AM
0 responses
12 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 08:47 AM
0 responses
16 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-11-2024, 12:08 PM
0 responses
61 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 10:19 PM
0 responses
60 views
0 likes
Last Post seqadmin  
Working...
X